300 related articles for article (PubMed ID: 25698590)
21. Recent progress in the diagnosis and treatment of primary vitreoretinal lymphoma.
Zhou M; Xu G
Taiwan J Ophthalmol; 2016; 6(4):170-176. PubMed ID: 29018736
[TBL] [Abstract][Full Text] [Related]
22. Primary vitreoretinal lymphoma: prevalence, impact, and management challenges.
Venkatesh R; Bavaharan B; Mahendradas P; Yadav NK
Clin Ophthalmol; 2019; 13():353-364. PubMed ID: 30858685
[TBL] [Abstract][Full Text] [Related]
23. Prognosis, Risk Factors, and Clinical Features of Intraocular Recurrence in Primary Vitreoretinal Lymphoma.
Liu S; Jiang T; Gu J; Zhou X; Chen W; Ping B; Zhou Y; Zhang T; Huang X; Xu G; Chang Q
Ophthalmol Retina; 2024 Apr; 8(4):317-324. PubMed ID: 37918656
[TBL] [Abstract][Full Text] [Related]
24. Diagnosis and management of vitreoretinal lymphoma: present and future treatment perspectives.
Kaburaki T; Taoka K
Jpn J Ophthalmol; 2023 Jul; 67(4):363-381. PubMed ID: 37209195
[TBL] [Abstract][Full Text] [Related]
25. Primary intraocular lymphoma.
Sagoo MS; Mehta H; Swampillai AJ; Cohen VM; Amin SZ; Plowman PN; Lightman S
Surv Ophthalmol; 2014; 59(5):503-16. PubMed ID: 24560125
[TBL] [Abstract][Full Text] [Related]
26. An unusual case report of primary vitreoretinal lymphoma.
Tan SZ; Steeples LR; Chhabra R; Jones NP
BMC Ophthalmol; 2018 Sep; 18(Suppl 1):223. PubMed ID: 30255824
[TBL] [Abstract][Full Text] [Related]
27. Clinical review: treatment of vitreoretinal lymphoma.
Pe'er J; Hochberg FH; Foster CS
Ocul Immunol Inflamm; 2009; 17(5):299-306. PubMed ID: 19831557
[TBL] [Abstract][Full Text] [Related]
28. CD79B mutations in primary vitreoretinal lymphoma: Diagnostic and prognostic potential.
Yonese I; Takase H; Yoshimori M; Onozawa E; Tsuzura A; Miki T; Mochizuki M; Miura O; Arai A
Eur J Haematol; 2019 Feb; 102(2):191-196. PubMed ID: 30390359
[TBL] [Abstract][Full Text] [Related]
29. [Research progress in the diagnosis of primary vitreoretinal lymphoma].
Tuo YR; Zhang MF
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):954-959. PubMed ID: 37936364
[TBL] [Abstract][Full Text] [Related]
30. A diagnostic challenge of primary Central nervous system lymphoma: from the eyes to the brain.
Su M; Huang D; Sun L; Dong Z; Wu L; Yu S
Int J Neurosci; 2021 Nov; 131(11):1139-1145. PubMed ID: 32449877
[TBL] [Abstract][Full Text] [Related]
31. [Primary vitreoretinal lymphoma].
Jaehne D; Coupland SE
Ophthalmologe; 2018 Apr; 115(4):343-356. PubMed ID: 29589147
[TBL] [Abstract][Full Text] [Related]
32. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study.
Riemens A; Bromberg J; Touitou V; Sobolewska B; Missotten T; Baarsma S; Hoyng C; Cordero-Coma M; Tomkins-Netzer O; Rozalski A; Tugal-Tutkun I; Guex-Crosier Y; Los LI; Bollemeijer JG; Nolan A; Pawade J; Willermain F; Bodaghi B; ten Dam-van Loon N; Dick A; Zierhut M; Lightman S; Mackensen F; Moulin A; Erckens R; Wensing B; le Hoang P; Lokhorst H; Rothova A
JAMA Ophthalmol; 2015 Feb; 133(2):191-7. PubMed ID: 25412269
[TBL] [Abstract][Full Text] [Related]
33. Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma.
Anthony CL; Bavinger JC; Shantha JG; O'Keefe GD; Pearce WA; Voloschin A; Grossniklaus HE; Yeh S
Int J Retina Vitreous; 2021 Dec; 7(1):72. PubMed ID: 34863313
[TBL] [Abstract][Full Text] [Related]
34. Refractory Primary Vitreoretinal Lymphoma Involving the Spinal Cord with a Temporary Complete Response to Tirabrutinib.
Iizuka-Honma H; Takizawa H; Mitsumori T; Okura H; Ishii H; Noguchi M
Intern Med; 2023 Feb; 62(3):459-463. PubMed ID: 35793963
[TBL] [Abstract][Full Text] [Related]
35. Association between ocular findings and preventive therapy with onset of central nervous system involvement in patients with primary vitreoretinal lymphoma.
Hashida N; Nakai K; Saitoh N; Nishida K
Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):687-93. PubMed ID: 24549401
[TBL] [Abstract][Full Text] [Related]
36. Molecular biomarkers for the diagnosis of primary vitreoretinal lymphoma.
Wang Y; Shen D; Wang VM; Sen HN; Chan CC
Int J Mol Sci; 2011; 12(9):5684-97. PubMed ID: 22016619
[TBL] [Abstract][Full Text] [Related]
37. DEVELOPMENT OF EPSTEIN-BARR VIRUS UVEITIS AFTER REMISSION OF PRIMARY VITREORETINAL LYMPHOMA.
Chahal BS; Rasmussen S; White VA; Forooghian F
Retin Cases Brief Rep; 2016; 10(2):131-3. PubMed ID: 26267526
[TBL] [Abstract][Full Text] [Related]
38. Neoplasia and intraocular inflammation: From masquerade syndromes to immunotherapy-induced uveitis.
Touhami S; Audo I; Terrada C; Gaudric A; LeHoang P; Touitou V; Bodaghi B
Prog Retin Eye Res; 2019 Sep; 72():100761. PubMed ID: 31091471
[TBL] [Abstract][Full Text] [Related]
39. Bilateral radiation therapy followed by methotrexate-based chemotherapy for primary vitreoretinal lymphoma.
de la Fuente MI; Alderuccio JP; Reis IM; Omuro A; Markoe A; Echegaray JJ; Davis JL; Harbour JW; Lossos IS
Am J Hematol; 2019 Apr; 94(4):455-460. PubMed ID: 30663807
[TBL] [Abstract][Full Text] [Related]
40. Rapid Resolution of Presumed Vitreoretinal Lymphoma With Systemic Ibrutinib Therapy.
Mathai M; Fein JG
Ophthalmic Surg Lasers Imaging Retina; 2021 Apr; 52(4):227-230. PubMed ID: 34039188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
